BSE: BIOCON - Biocon Limited

六个月盈利: -1.59%

促销时间表 Biocon Limited

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services.

更多详情
The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

EBITDA 17.33
EV/EBITDA 21.24
ISIN INE376G01013
Industry Biotechnology
P/BV 6.01
P/E 40.49
P/S 6.65
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 55.14
Див.доход ао 0.57
Дивиденд ао 1.5
Сайт https://www.biocon.com
Цена ао 359.05
Число акций ао 1.2006 млрд
每日价格变化: +1.56% (346.45)
每周价格变化: +4.73% (335.95)
每月价格变化: -2.05% (359.2)
3个月内价格变化: -4.57% (368.7)
六个月内的价格变化: -1.59% (357.55)
每年价格变化: +42.25% (247.35)
3年内价格变化: +0.4712% (350.2)
5年内价格变化: +38.22% (254.55)
10年价格变化: 0% (351.85)
年初以来价格变化: +0.285% (350.85)
所有参数

低估

姓名 意义 年级
P/S 2.13 7
P/BV 1.19 9
P/E 29.51 6
EV/EBITDA 16.97 6
全部的: 7

效率

姓名 意义 年级
ROA, % 1.89 1
ROE, % 5.43 2
全部的: 2.17

股息

姓名 意义 年级
Div yield, % 0.4195 1.05
DSI 0.9286 9.29
全部的: 2.2

责任

姓名 意义 年级
Debt/EBITDA 6.48 0
全部的: 3.4

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 125.31 10
盈利能力 Ebitda, % 40.16 6
盈利能力 EPS, % 37.03 5
全部的: 5.2
更多详情

ETF 分享, % 本年盈利能力, % 股息, %
iShares MSCI India Small-Cap ETF 0.44091 5.44 0.96163
iShares MSCI Emerging Markets Small-Cap ETF 0.13861 7.67 2.7853
Franklin FTSE India ETF 0.11361 20.52 1.25133
WisdomTree India Earnings Fund 0.03674 9.16 1.65591
JPMorgan ActiveBuilders Emerging Markets Equity ETF 0.03636 7.84 3.1658
SPDR Portfolio Emerging Markets ETF 0.02908 10.83 3.1879
Avantis Responsible Emerging Markets Equity ETF 0.0279 17.6 3.1719
Franklin FTSE Asia ex Japan ETF 0.02659 14.43 2.66768
Dimensional Emerging Markets Value ETF 0.01912 17.07 4.19508
John Hancock Multifactor Emerging Markets ETF 0.01141 3.94 3.42078
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01046 12.46 3.59676
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.01012 1.5 4.35382
Vanguard ESG International Stock ETF 0.01 4.9 3.07501
iShares Core MSCI Total International Stock ETF 0.00917 4.37 3.25258
Avantis Emerging Markets Equity ETF 0.00884 7.19 3.60513
Dimensional Emerging Markets Core Equity 2 ETF 0.00859 15.96 3.34087
Dimensional World ex U.S. Core Equity 2 ETF 0.00222 13.06 3.62488

导师 职称 支付 出生年份
Mr. Siddharth Mittal BCom, CA, CPA MD, CEO & Director 47.88M 1978 (47 年)
Mr. Saurabh Paliwal Head of Investor Relations N/A
Mr. Mayank Verma Company Secretary & Compliance Officer 5.75M
Ms. Seema Shah Ahuja BA, MBA Global Head of Communications & Corporate Brand N/A 1966 (59 年)
Mr. Peter James Jonathan Bains Group Chief Executive Officer 3.28M 1957 (68 年)
Mr. Arun Gupta Head of Operations N/A
Mr. Atanu Roy Group Chief Information Officer N/A
Ms. Maninder Kapoor Puri Head of Human Resources N/A 1973 (52 年)
Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc. Founder & Executive Chairperson 1953 (72 年)
Mr. Mukesh Kamath Chief Financial Officer

地址: India, Bengaluru, 20th KM Hosur Road - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.biocon.com